TP53 and breast cancer: In ER-positive BC, the median OS of TP53-mutated BC was 32.6 months compared to 88.5 months in wild type TP53 (median OS (wild type vs. mutated): 88.5 ± 54.4 vs. 32.6 ± 10.7 (months), p = 0.002).